Strategies for Life Sciences Firms in a Bear Market

Posted by Jason Greis on November 18, 2008 under Events | Be the First to Comment |  Print

Thursday, December 11, 2008
11:30 a.m. – 12:45 p.m. (EST)

The credit crunch has created significant issues for life science companies seeking to grow. The inability to raise funds through an initial public offering, combined with the exit of major private equity funds from the market, has forced growing biotech and medical device companies to stay private longer and seek alternative financing. This is creating a significant upswing in merger and acquisition and partnership activities within the life science market. Our diverse, interactive panel—including a banker, a venture capitalist and outside counsel—will discuss the following: 

• Collaboration strategies between public and private life science firms
• Predictions for 2009 biotech and device M&A activities
• Strategies for attracting funding from diverse public and private sources
• Alternative financing routes and creative deal structures

Speakers:

• Frank Stokes, Managing Director, Robert W. Baird & Co., Inc.
• Scott Weiner, Principal, Pappas Ventures
• Krist Werling, McGuireWoods LLP
• Bart Walker, McGuireWoods LLP

For additional information, contact Carmen Paige at cpaige@mcguirewoods.com.  One week prior to the webinar, registrants will receive confirmation, a web address to access the link, and dial-in instructions. CLE credits pending.